Bret Berner
Corporate Officer/Principal at Ditullio & Lacorte Associates LLC
Profile
Bret Berner is Chief Scientific Officer of Cogentus Pharmaceuticals, Inc. Prior to joining Cogentus, Dr. Berner was Vice President of Product Development and Chief Scientific Officer at Depomed.
He was Vice President of Development at Cygnus, Inc. for four years.
Previously, Dr. Berner served as Director of Basic Pharmaceutics Research for Ciba-Geigy from 1984 to 1994.
He was Staff Scientist for The Procter & Gamble Co. He has 28 years of experience in health products and R&D.
Dr. Berner received a BA degree in Neurosciences from the University of Rochester and a PhD in Physical Chemistry from the University of California, Los Angeles.
Bret Berner active positions
| Companies | Position | Start |
|---|---|---|
| Ditullio & Lacorte Associates LLC | Corporate Officer/Principal | - |
Former positions of Bret Berner
| Companies | Position | End |
|---|---|---|
Cogentus Pharmaceuticals, Inc.
 Cogentus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cogentus Pharmaceuticals, Inc. develops pharmaceutical products. Its investors include The Keffi Group, Prospect Venture Partners, Ridgeback Capital, Apothecary Capital, and Pinnacle Ventures. The company was founded by Mark A. Goldsmith in 2006 and is headquartered in Menlo Park, CA | Chief Tech/Sci/R&D Officer | 18/12/2009 |
| PROCTER & GAMBLE COMPANY | Corporate Officer/Principal | - |
Cygnus, Inc.
 Cygnus, Inc. Medical SpecialtiesHealth Technology Cygnus, Inc. develops and manufactures glucose-monitoring devices. The company develops devices that provide data to individuals and physicians to enable them to manage diabetes. It was founded in 1985 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | - |
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Chief Tech/Sci/R&D Officer | - |
Training of Bret Berner
| Rochester Christian University | Undergraduate Degree |
| University of California, Los Angeles | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PROCTER & GAMBLE COMPANY | Consumer Non-Durables |
| Private companies | 4 |
|---|---|
Cygnus, Inc.
Cygnus, Inc. Medical SpecialtiesHealth Technology Cygnus, Inc. develops and manufactures glucose-monitoring devices. The company develops devices that provide data to individuals and physicians to enable them to manage diabetes. It was founded in 1985 and is headquartered in San Francisco, CA. | Health Technology |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
Cogentus Pharmaceuticals, Inc.
Cogentus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cogentus Pharmaceuticals, Inc. develops pharmaceutical products. Its investors include The Keffi Group, Prospect Venture Partners, Ridgeback Capital, Apothecary Capital, and Pinnacle Ventures. The company was founded by Mark A. Goldsmith in 2006 and is headquartered in Menlo Park, CA | Health Technology |
| Ditullio & Lacorte Associates LLC |
- Stock Market
- Insiders
- Bret Berner
